Last reviewed · How we verify
Prophylactic ondansetron
At a glance
| Generic name | Prophylactic ondansetron |
|---|---|
| Sponsor | Hospital de Base |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) (NA)
- Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days (EARLY_PHASE1)
- Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer
- Role of Prophylactic Antiemetics in Women Receiving Intrathecal Morphine and Lipophilic Opioids Added to Bupivacaine for Cesarean Section (PHASE4)
- AoA Guided Thoracic Epidural Analgesia for Abdominal Aortic Repair (NA)
- Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP (NA)
- Ondansetron Prior Spinal Anaesthesia
- Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prophylactic ondansetron CI brief — competitive landscape report
- Prophylactic ondansetron updates RSS · CI watch RSS
- Hospital de Base portfolio CI